Biotechnology and Medical Research (TRBC)

Roche takes on Loxo, Bayer in gene-defined cancer class

Roche takes on Loxo, Bayer in gene-defined cancer class

Published 21/10/2018

MUNICH (Reuters) - Roche’s entrectinib cancer pill was shown to shrink tumors in 57 percent of patients within a group that can only be identified [more…]

Roche scores win in slowing aggressive type of breast cancer

Roche scores win in slowing aggressive type of breast cancer

Published 20/10/2018

ZURICH/MUNICH (Reuters) - An immunotherapy cocktail from Roche helped slow an aggressive type of breast cancer where new treatments have proven elusive, offering positive news [more…]

Merck, Pfizer combo treatment meets main goals of kidney cancer trial

Merck, Pfizer combo treatment meets main goals of kidney cancer trial

Published 18/10/2018

(Reuters) - Merck & Co said on Thursday a combination treatment of its cancer drug Keytruda and Pfizer Inc’s Inlyta met the main goals of [more…]

Akcea Therapeutics genetic disease treatment gets FDA approval

Akcea Therapeutics genetic disease treatment gets FDA approval

Published 05/10/2018

(Reuters) - Akcea Therapeutics Inc said on Friday its treatment, developed along with Ionis Pharmaceuticals , which targets a rare genetic disease was approved by [more…]

EMA committee recommends restrictions on fluoroquinolone, quinolone…

EMA committee recommends restrictions on fluoroquinolone, quinolone…

Published 05/10/2018

(Reuters) - The European Medicines Agency’s risk assessment committee has recommended restrictions on the use of broad-spectrum antibiotics fluoroquinolone and quinolone following a review of [more…]

Trio wins chemistry Nobel for work on antibody drugs, smart enzymes

Trio wins chemistry Nobel for work on antibody drugs, smart enzymes

Published 04/10/2018

STOCKHOLM/LONDON (Reuters) - Two Americans and a Briton won the 2018 Nobel Prize for Chemistry on Wednesday for harnessing the power of evolution to generate [more…]

Insmed’s treatment-resistant lung disease drug gets FDA approval

Insmed’s treatment-resistant lung disease drug gets FDA approval

Published 28/09/2018

(Reuters) - The U.S. Food and Drug Administration on Friday approved Insmed Inc’s lead drug to treat a rare, chronic lung disease, making it the [more…]

Sanofi, Regeneron skin cancer drug gets FDA nod

Sanofi, Regeneron skin cancer drug gets FDA nod

Published 28/09/2018

(Reuters) - Sanofi SA said on Friday its skin cancer drug, made in partnership with Regeneron Pharmaceuticals Inc, was approved by the U.S. Food and [more…]

U.S. fund investors move to domestic stocks for third straight week

U.S. fund investors move to domestic stocks for third straight week

Published 27/09/2018

NEW YORK (Reuters) - U.S. fund investors rotated from international to domestic stocks for a third straight week, showing continued signs of risk aversion given [more…]

As China builds biotech sector, cash floods U.S. startups

As China builds biotech sector, cash floods U.S. startups

Published 24/09/2018

SAN FRANCISCO/HONG KONG (Reuters) - For three whirlwind days in June, U.S. scientist Zhi Hong went shopping at the Boston Bio Conference to find drugs [more…]